- VIRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Viracta Therapeutics (VIRX) 10-K/A2006 FY Annual report (amended)
Filed: 23 May 07, 12:00am
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Sunesis Pharmaceuticals, Inc. |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: May 23, 2007 | ||
/s/ Eric H. Bjerkholt | ||
Eric H. Bjerkholt | ||
Senior Vice President, Corporate Development and | ||
Finance, Chief Financial Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.